Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy

被引:0
|
作者
Li Zhuo
Nianrong Zhang
Guming Zou
Dapeng Chen
Wenge Li
机构
[1] China–Japan Friendship Hospital,Department of Nephrology
来源
Frontiers of Medicine | 2017年 / 11卷
关键词
diabetic nephropathy; clinical characteristics; renal biopsy; outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
Kidney damage is common in patients with diabetes mellitus (DM). However, whether the type of kidney damage can be reliably diagnosed using clinical data alone remains unclear. Predictive factors for diabetic nephropathy (DN) outcomes are also poorly understood. In this study, the clinical manifestations of 111 cases of biopsy-proven DN were described, and the clinical and pathological parameters of patients with different DN outcomes were compared. Results showed that long DM duration ( > 10 years in 32.4% of patients), severe proteinuria (62.2%), and renal dysfunction (estimated glomerular filtration rate [eGFR] < 60 mL/(min$1.73 m2)) (52.3%) did not accurately indicate whether the condition of these patients progressed to DN. Hematuria (48.6%) failed to specify either DN or nondiabetic renal disease. Diabetic retinopathy (78.4%) was a crucial complication in patients with DN. Kaplan–Meier analysis revealed that the renal survival of 53 patients who were diagnosed with DN and were followed up was not significantly associated with glomerular classification (P > 0.05). Cox’s regression analysis demonstrated that renal survival time was significantly influenced by sex (β = 1.394, P = 0.038), hematuria (β = 0.036, P = 0.029), and eGFR (β =–0.039, P = 0.002) but was not significantly affected by age, 24 h urinary protein excretion, or glomerular classification (P > 0.05). In conclusion, the clinical characteristics of DN vary, and renal biopsy is necessary to determine renal damage patterns. Sex, hematuria, and the eGFR may affect DN outcomes, whereas the glomerular classification may not.
引用
收藏
页码:386 / 392
页数:6
相关论文
共 50 条
  • [31] Magnetic Resonance Imaging of Diabetic Foot Osteomyelitis: Imaging Accuracy in Biopsy-Proven Disease
    La Fontaine, Javier
    Bhavan, Kavita
    Jupiter, Daniel
    Lavery, Lawrence A.
    Chhabra, Avneesh
    JOURNAL OF FOOT & ANKLE SURGERY, 2021, 60 (01) : 17 - 20
  • [32] Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis
    Haruhara, Kotaro
    Tsuboi, Nobuo
    Kanzaki, Go
    Koike, Kentaro
    Suyama, Masahiro
    Shimizu, Akihiro
    Miyazaki, Yoichi
    Kawamura, Tetsuya
    Ogura, Makoto
    Yokoo, Takashi
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (09) : 1164 - 1171
  • [33] Epidemiology of biopsy-proven glomerulonephritis in Queensland adults
    Jegatheesan, Dev
    Nath, Karthik
    Reyaldeen, Reza
    Sivasuthan, Goutham
    John, George T.
    Francis, Leo
    Rajmokan, Mohana
    Ranganathan, Dwarakanathan
    NEPHROLOGY, 2016, 21 (01) : 28 - 34
  • [34] Histopathological and Clinical Findings of Biopsy-Proven Focal and Segmental Glomerulosclerosis: A Retrospective Study
    Alhozali, Hanadi M.
    Ahmed, Renad A.
    Albeirouti, Rasana B.
    Alotibi, Fahad A.
    Ghazi, Deemah K.
    Shikdar, Mohammad A.
    Alghamdi, Maha K.
    Al Zahrani, Reem A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [35] Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis
    Chou, Yu-Hsiang
    Lin, Wei-Chou
    Chen, Yung-Ming
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 148 : 144 - 151
  • [36] A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes
    Yu, D.
    Shang, J.
    Cai, Y.
    Wang, Z.
    Zhao, B.
    Zhao, Z.
    Simmons, D.
    DIABETIC MEDICINE, 2020, 37 (10) : 1728 - 1736
  • [37] Diagnostic and therapeutic considerations in biopsy-proven type 2 autoimmune pancreatitis: comparative analysis with biopsy-proven type 1 autoimmune pancreatitis
    Pattabathula, Krishna
    Waters, Peadar S.
    Hwang, Jason
    Bettington, Mark
    Singh, Mahendra
    Bryant, Richard D.
    Cavallucci, David J.
    O'Rourke, Nicholas
    ANZ JOURNAL OF SURGERY, 2021, 91 (05) : 907 - 914
  • [38] Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
    Sibei Tao
    Lingzhi Li
    Ling Li
    Yuan Liu
    Qian Ren
    Min Shi
    Jing Liu
    Jing Jiang
    Huichao Ma
    Zhuo Huang
    Zijing Xia
    Jing Pan
    Tiantian Wei
    Yan Wang
    Peiyun Li
    Tian Lan
    Xi Tang
    Xiaoxi Zeng
    Song Lei
    Huairong Tang
    Liang Ma
    Ping Fu
    Acta Diabetologica, 2019, 56 : 581 - 592
  • [39] Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
    Lu, Haitao
    Xu, Qianqian
    Zou, Guming
    Gao, Hongmei
    Yang, Yue
    Li, Wenge
    Zhuo, Li
    RENAL FAILURE, 2024, 46 (01)
  • [40] Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis
    Corthier, Alice
    Jachiet, Marie
    Bertin, Daniel
    Servais, Aude
    Barbet, Christelle
    Bigot, Adrien
    Doutre, Marie-Sylvie
    Bessis, Didier
    Bouffandeau, Ancuta
    Moranne, Olivier
    Jarrot, Pierre-Andre
    Bardin, Nathalie
    Terrier, Benjamin
    Burtey, Stephane
    Puechal, Xavier
    Daniel, Laurent
    Jourde-Chiche, Noemie
    BMC NEPHROLOGY, 2022, 23 (01)